i have hydrocodone they are white and round with 524 on them, what are they?

Answer 1

what you have is hydrocodone and ibuprofen ( brand name vicoprofen).

Answer 2

This Site Might Help You.

RE:
i have hydrocodone they are white and round with 524 on them, what are they?

Answer 3

524 Pill

Answer 4

hydrocodone also known as vicodin, loratabs, ex-vic is a pain medication. If you don't know what they are for what the hell are you doing with them. Playing with pain medication is not very smart. All it takes is you to have an allergic reaction and it may be the last pill you see.

Answer 5

Hydrocodone is generic for Vicodin.

Answer 6

hydrocodone contains a sub-Codeine which is illegal to have if you do not have a prescription. it is well known for its recreational use!! effects include (but are not limited to) silliness, euphoria, "munchies", and tiredness.

Answer 7

it's generic Vicodin, a narcotic pain medication.

Answer 8

they are hydrocodone, you just stated that.....

Answer 9

Hydrocodone dosing information

Usual Adult Dose for Chronic Pain:
The following dosing recommendations can only be considered suggested approaches to what is actually a series of clinical decisions over time; each patient should be managed individually. As First Opioid Analgesic and For Patients who are NOT Opioid Tolerant:Extended-Release Capsules (Zohydro(R) ER): Initial dose: 10 mg orally every 12 hoursExtended-Release Tablets (Hysingla(R) ER): Initial dose: 20 mg orally every 24 hoursComments:-Use of higher starting doses in patients who are not opioid tolerant may cause fatal respiratory depression; monitor patients closely for respiratory depression, especially during the first 24 to 72 hours.-An opioid tolerant patient is one who has been receiving for 1-week or longer at least: oral morphine 60 mg/day, fentanyl transdermal patch 25 mcg per hour, oral oxycodone 30 mg/day, oral hydromorphone 8 mg/day, oral oxymorphone 25 mg/day, or an equianalgesic dose of another opioid. TITRATION AND MAINTENANCE:Individually titrate to a dose that provides adequate analgesia and minimizes adverse reactions.--Dose adjustments to hydrocodone extended-release capsules should be made in 10 mg increments every 12 hours, every 3 to 7 days. --Dose adjustments to hydrocodone extended-release tablets should be made in 10 to 20 mg increments every 24 hours, every 3 to 5 days.--If unacceptable side effects occur, the dose may be reduced.Breakthrough Pain: If the level of pain increases after dose stabilization, attempt to identify the source before increasing dose; rescue medication with appropriate immediate-release analgesia may be helpful DOSE CONVERSIONS: Dose conversions should be done carefully and with close monitoring due to large patient variability in regards to opioid analgesic response. Discontinue all other around the clock opioid drugs when initiating therapy with extended-release hydrocodone.Hydrocodone Extended-Release (ER) CAPSULES:-The 50 mg capsules, a single dose greater than 40 mg, or a total daily dose greater than 80 mg are reserved for opioid tolerant individuals.CONVERSION FROM OTHER ORAL OPIOIDS:-Published potency tables can be used to estimate a patient's 24-hour oral hydrocodone requirement; however, due to substantial inter-patient variability, it is best to underestimate a patient's 24-hour requirement and provide rescue medication as the dose is titrated. -Alternatively, the following conversion factors (CF) may be used to convert selected oral opioids to the hydrocodone extended-release capsule: Hydrocodone, CF=1; Oxycodone, CF=1; Methadone, CF= 1, Oxymorphone, CF=2; Hydromorphone, CF=2.67; Morphine, CF=0.67; Codeine, CF=0.1. -These CFs cannot be used to convert from hydrocodone extended-release to the selected oral opioid as doing so will result in overestimation of the oral opioid dose and may result in fatal respiratory depression. -Example: Sum the total daily dose of prior oral opioid; multiply that sum by the CF to obtain 24-hour oral hydrocodone requirement; divide 24-hour requirement by 2 (round down, if necessary ) and give 1 dose orally every 12 hours. CONVERSION FROM TRANSDERMAL FENTANYL: Remove the transdermal fentanyl patch and 18 hours later initiate hydrocodone extended-release capsules at 10 mg every 12 hours for each 25 mcg/hr fentanyl transdermal patch; monitor closely as there is limited documented experience with this conversion. Hydrocodone Extended-Release (ER) TABLETS: -Daily dose greater than or equal to 80 mg are reserved for use in opioid tolerant individuals.-CONVERSION FROM ORAL HYDROCODONE FORMULATIONS: Administer patient's total daily oral hydrocodone dose as extended-release tablet orally once a day.-CONVERSION FROM OTHER ORAL OPIOIDS:-Published potency tables can be used to estimate a patient's 24-hour oral hydrocodone requirement; however, due to substantial inter-patient variability, it is best to underestimate a patient's 24-hour requirement and provide rescue medication as the dose is titrated. -To obtain the initial hydrocodone extended-release tablet dose, use the following conversion factors (CF) to convert selected oral opioids and then reduce that dose by 25%. Tramadol, CF=0.1; Oxycodone, CF=1; Methadone, CF= 1.5, Oxymorphone, CF=2; Hydromorphone, CF=4; Morphine, CF=0.5; Codeine, CF=0.15. -These CFs cannot be used to convert from hydrocodone extended-release to the selected oral opioid as doing so will result in overestimation of the oral opioid dose and may result in fatal respiratory depression. -Example: Sum the total daily dose of prior oral opioid; multiply that sum by the CF to obtain 24-hour oral hydrocodone requirement; reduce that hydrocodone requirement by 25% to account for interpatient variability, round down, if necessary; administer calculated dose orally once a day. CONVERSION FROM TRANSDERMAL FENTANYL: Remove the transdermal fentanyl patch and 18 hours later initiate hydrocodone extended-release tablets at 20 mg every 24 hours for each 25 mcg/hr fentanyl transdermal patch; monitor closely as there is limited documented experience with this conversion. CONVERSION FROM TRANSDERMAL BUPRENORPHINE: Patients receiving transdermal buprenorphine 20 mcg/hr or less should initiate extended-release hydrocodone tablets at 20 mg every 24 hours; monitor closely as there is limited documented experience with this conversion. Comments:-When converting from methadone, close monitoring is of particular importance due to methadone's long half-life. Use: For the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.


Visit This Trusted Mall (no Prescription) >>>> http://hydrocodone1.out2.pw/o6a4h